Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal symptoms followed by psychotherapy in mpatient and/or outpatient settings. Treatment goals include abstinence and reduced alcohol consumption. Standard treatment for alcoholism has a high rate of success in Germany; however, for various reasons, only a small percentage of alcoholic patients are admitted to alcoholism treatment programmes. A new drug, acamprosate, could benefit many more alcoholic patients. Several studies indicate that acamprosate reduces the craving for alcohol and enhances abstinence. Acamprosate's effect is dose-dependent and it has a few minor side-effects. In addition, the availability of acamprosate may enable fami...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
advance access publication 6 June 2005) Abstract — Aims: This review assessed the published data on ...
Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal ...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Acamprosate (calcium bis acetylhomotaurinate) is a new medication that appears to be clinically usef...
Abstract: Acamprosate, a medication that has been used in Europe for years, is the newest drug to be...
To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treate...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Acamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show t...
"The alcoholism can also deal with drug treatments." This is the message that emerges from the press...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Katie Witkiewitz, Kimber Saville, Kacie HamreusDepartment of Psychology, Washington State University...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
advance access publication 6 June 2005) Abstract — Aims: This review assessed the published data on ...
Abstract — Standard treatment for alcohol abuse may include pharmacotherapy to alleviate withdrawal ...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Acamprosate (calcium bis acetylhomotaurinate) is a new medication that appears to be clinically usef...
Abstract: Acamprosate, a medication that has been used in Europe for years, is the newest drug to be...
To assess the effectiveness of pharmacotherapy with acamprosate in alcohol-dependent patients treate...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Acamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show t...
"The alcoholism can also deal with drug treatments." This is the message that emerges from the press...
Treatment with acamprosate is a valid tool to complement psychotherapy as it does not cause addictio...
Katie Witkiewitz, Kimber Saville, Kacie HamreusDepartment of Psychology, Washington State University...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
advance access publication 6 June 2005) Abstract — Aims: This review assessed the published data on ...